Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40⁻CD154 Costimulatory Protein-Protein Interaction

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Damir BojadzicPeter Buchwald

Abstract

We report the design, synthesis, and testing of novel small-molecule compounds targeting the CD40⁻CD154 (CD40L) costimulatory interaction for immunomodulatory purposes. This protein-protein interaction (PPI) is a TNF-superfamily (TNFSF) costimulatory interaction that is an important therapeutic target since it plays crucial roles in the activation of T cell responses, and there is resurgent interest in its modulation with several biologics in development. However, this interaction, just as all other PPIs, is difficult to target by small molecules. Following up on our previous work, we have now identified novel compounds such as DRI-C21091 or DRI-C21095 that show activity (IC50) in the high nanomolar to low micromolar range in the binding inhibition assay and more than thirty-fold selectivity versus other TNFSF PPIs including OX40⁻OX40L, BAFFR-BAFF, and TNF-R1-TNFα. Protein thermal shift (differential scanning fluorimetry) assays indicate CD154 and not CD40 as the binding partner. Activity has also been confirmed in cell assays and in a mouse model (alloantigen-induced T cell expansion in a draining lymph node). Our results expand the chemical space of identified small-molecule CD40⁻CD154 costimulatory inhibitors and provide lea...Continue Reading

References

Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·N S KenyonC Ricordi
Dec 22, 1999·Respiratory Medicine·G M CochraneP Chanez
Mar 7, 2001·Cellular and Molecular Life Sciences : CMLS·U Schönbeck, P Libby
Feb 14, 2002·Trends in Biochemical Sciences·Jean-Luc BodmerJürg Tschopp
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·David H WagnerKathryn Haskins
Mar 23, 2004·Annual Review of Immunology·Sergio A QuezadaRandolph J Noelle
Apr 3, 2004·Nature Reviews. Drug Discovery·Michelle R Arkin, James A Wells
Apr 10, 2004·European Journal of Medicinal Chemistry·Matthias U KassackGünter Lambrecht
Feb 18, 2005·Journal of Medicinal Chemistry·Bruce L GrasbergerRoger F Bone
Dec 28, 2006·Nature Protocols·Brian Y Feng, Brian K Shoichet
Oct 26, 2007·Molecular Immunology·Maribel MirabetDavid Garcia-Dorado
Dec 22, 2007·Nature Reviews. Drug Discovery·Benjamin LeaderDavid E Golan
Jun 11, 2008·Pediatric Diabetes·Nick GiannoukakisMassimo Trucco
Oct 28, 2008·Journal of Autoimmunity·Rocky L BakerKathryn Haskins
Oct 29, 2008·Chemical Communications : Chem Comm·Yusuke AdachiNaoki Miyata
Nov 6, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ilaria DeambrosisGiovanni Camussi
Dec 26, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bryna E BurrellD Keith Bishop
Mar 14, 2009·Biochemical Pharmacology·Emilio Margolles-ClarkPeter Buchwald
May 12, 2009·Immunological Reviews·Raul ElguetaRandolph J Noelle
May 12, 2009·Immunological Reviews·Xian C LiMohamed H Sayegh
Jul 15, 2009·Seminars in Immunology·Anna L PetersGail A Bishop
Aug 27, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Emilio Margolles-ClarkPeter Buchwald
Oct 20, 2009·Drug Discovery Today·Malú G Tansey, David E Szymkowski
Jul 20, 2010·Chemical Biology & Drug Design·Emilio Margolles-ClarkPeter Buchwald
Jan 5, 2011·Diabetes·Jay S Skyler, Camillo Ricordi
Jan 12, 2011·Biochemical Pharmacology·Lakshmi GanesanPeter Buchwald
Jan 31, 2012·Bioorganic & Medicinal Chemistry·Muthusamy VenkatrajKoen Augustyns
Apr 11, 2012·European Journal of Immunology·Rocky L BakerKathryn Haskins
Aug 29, 2012·Internal and Emergency Medicine·Marco MoiaPier Mannuccio Mannucci
Jan 9, 2013·Nature Reviews. Endocrinology·Ake Lernmark, Helena Elding Larsson
Jan 22, 2013·Nature Reviews. Drug Discovery·Michael CroftCarl F Ware
Mar 9, 2013·Nature Reviews. Immunology·Lieping Chen, Dallas B Flies
Mar 29, 2013·Nature Reviews. Drug Discovery·Jean G SathishB Kevin Park
Jul 31, 2013·Lancet·Mark A AtkinsonAaron W Michels
Mar 29, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jenny H XieAnish Suri
Apr 17, 2014·Chemical Reviews·Lech-Gustav MilroyChristian Ottmann

❮ Previous
Next ❯

Methods Mentioned

BETA
thermal shift
PCR
column

Software Mentioned

GraphPad Prism
Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.